The PROTAC selectively degrading Bcl-x<sub>L</sub> represents a novel Hedgehog pathway inhibitor with capacity of combating resistance to Smoothened inhibitors while sparing bone growth

Shaoqing Zhang(Fudan University), Wenfu Tan(Fudan University)
Theranostics
January 1, 2022
Cited by 20


Related Papers